DUBLIN, Sept. 25, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement ...
Agreement to fund expansion of Rochester, MI facility to support fill-finish manufacturing of both mRNA and adenovirus vaccines The agreement is a result of efforts defined under the Defense ...
Endo will have $120 million to expand its fill-finish manufacturing operations in Michigan as part of a deal it inked with the federal government to produce critical medicines. Under the agreement, ...
"Endo strives to be a force for good, and we are proud to partner with the U.S. government in its efforts to expand and accelerate domestic manufacturing in support of future pandemic preparedness," ...